Skip to main content

Nasdaq Stocks

Zynex Plans To Buy Back $10M In Stock; Shares Jump Over 10%

5 years 8 months ago

Shares of Zynex closed 10.1% higher on Monday after the medical device manufacturer announced its plans to repurchase $10 million worth of shares.

Zynex (ZYXI) said that the repurchase program will commence immediately and is set to expire on Sep. 8, or before the buyback limit of $10 million is reached.

The company’s CEO Thomas Sandgaard said, “this buyback program authorization reflects the board's confidence in both our short-term prospects and our long term growth strategy.” He added that, “the buyback program represents an attractive opportunity to deploy capital in a way that will benefit stockholders.”

Last month, Zynex reported lower-than-expected 4Q results. The company reported 4Q earnings of $0.05 per share, which missed consensus estimates by a cent and fell 44.4% year-over-year. Revenues of $25.6 million grew 81% year-over-year but missed analysts’ expectations of $25.8 million. (See Zynex stock analysis on TipRanks)

Following the 4Q miss, B.Riley Financial analyst Marc Wiesenberger downgraded the stock to Hold from Buy and lowered the price target to $19 (17% upside potential) from $23. In a note to investors, the analyst said that the company provided a “wider than normal” FY21 guidance range. The analyst further lowered his FY21 estimates, given “deteriorating profitability and increased uncertainty.”

Overall, the Street has a Moderate Buy consensus rating based on 1 Buy and 3 Holds. The average analyst price target of $21.63 implies upside potential of over 33% to current levels. Shares have gained about 14.6% in one year.

Related News:
Dycom Plans $150M Share Buyback After 4Q Sales Beat; Stock Jumps 12.4%
CMC Materials Bumps Up Quarterly Dividend By 5%, Boosts Share Buyback Plan
Henry Schein Reinstates Share Buyback Plan; Street Sees 30% Upside

What's Happening With Sirius XM Stock?

5 years 8 months ago
Sirius XM’s stock (NASDAQ: SIRI) has declined only slightly over the last five days to levels of around $6 currently. But will the company’s stock see higher levels over the coming weeks, or is a further decline in the stock imminent? According to the Trefis Machine

Here's Why We Believe Walgreens Stock In Undervalued At $47

5 years 8 months ago
The stock price of Walgreens Boots Alliance (NYSE:WBA) looks attractive at current levels of $47, as it is up a mere 7% from the levels it was on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks a significant underperformance com

After 22% Rally, Is Tapestry Stock Poised For Further Gains?

5 years 8 months ago
Tapestry’s (NYSE: TPR) stock, a luxury goods retailer of handbags, shoes, and accessories under the Coach, Kate Spade, and Stuart Weitzman has increased by almost 22% over the last month (twenty-one trading days) and currently stands at around $41. The market reacted upwa

Bed Bath & Beyond Stock To Fall After Climbing 200% ?

5 years 8 months ago
Bed Bath & Beyond stock (NASDAQ: BBBY), a home goods retailer, saw its revenue decline 14% to a consolidated figure of $9.7 Bil for the last 4 quarters from the consolidated figure of $11.34 Bil for the 4-quarter period before that. Despite this, BBBY stock has gained a who

Is Whirlpool Stock Still Attractive After A Solid 3x Rally?

5 years 8 months ago
Whirlpool’s stock (NYSE: WHR), a manufacturer and marketer of major home appliances, is about 2.8x higher than the levels on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This compares with a 68% rise for the S&P over the same perio

Penn Virginia (PVAC) Tops Q4 Earnings Estimates

5 years 8 months ago
Penn Virginia (PVAC) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $2.75 per share a year ago. These figures are adjusted for non-recurring items.

Harrow Health (HROW) Lags Q4 Earnings Estimates

5 years 8 months ago
Harrow Health (HROW) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
Checked
2 minutes 2 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed